News tagged with acute coronary syndromes

Related topics: heart attack

Adverse events not up with six months of DAPT

(HealthDay)—For patients receiving an everolimus-eluting stent implantation, six months of dual antiplatelet therapy (DAPT) does not increase composite events compared with 12 months of DAPT, according to a study published ...

May 19, 2016
popularity1 comments 0

Cilostazol doesn't prevent periprocedural MI in ACS

(HealthDay)—For patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), adjunctive loading dose of cilostazol is not associated with prevention of periprocedural myocardial infarction ...

May 09, 2016
popularity1 comments 0

No benefit to prolonging bivalirudin after PCI

Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the ...

Sep 01, 2015
popularity10 comments 0

ELIXA trial shows CV safety of Lixisenatide

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...

Aug 31, 2015
popularity9 comments 0

Subscribe to rss feed